MedTrace Logo

CFfone: A Cell Phone Support Program for Adolescents With Cystic Fibrosis

NCT01183286 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2010-08-17

No results posted yet for this study

Summary

Adolescents with cystic fibrosis are particularly vulnerable to poor adherence, which negatively impacts their health status, quality of life and long term survival. CFFONE: A Cell Phone Support Program for Adolescents with Cystic Fibrosis, will make use of cutting-edge technology- a broadband capable, cellular telephone keyed into a highly-interactive informational web site. This web site will provide engaging online learning activities and resources specific to adolescents with cystic fibrosis. We believe the information and activities contained in CFFONE will improve adolescents knowledge, attitudes, and practices around cystic fibrosis and that adolescents exposed to the CFFONE program will demonstrate an increase in adherence to their treatment regimens and related improvements in their health status and quality of life.

Conditions

Interventions

BEHAVIORAL

CFFONE

A password-protected, secure website, which can be accessed via a web capable cell phone. The website contains age appropriate medical and behavioral information, disease management tools and social networking features for adolescents and young people who have Cystic Fibrosis.

BEHAVIORAL

CF website

A CF-related educational website which has some areas of CF information and services relevant to adolescents.

Sponsors & Collaborators

  • University of Miami

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • University of Tennessee

    collaborator OTHER

  • Children's National Research Institute

    collaborator OTHER

  • Dawkins Productions, Inc.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-04-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01183286 on ClinicalTrials.gov